Wouter L J Hinrichs (Wouter Lj Hinrichs)

DAI Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Topics

Molecularly Imprinted

High Fat Diet Induced

Platelet Rich Plasma

Top Venues

Expert review of vaccines

This page only lists publications with an associated author ORCID identifier.

Publications

Kurnia S S Putri, Adhyatmika Adhyatmika, Carian E Boorsma, Habibie Habibie, Mitchel J R Ruigrok, Peter Heukels, Hidde J Haisma, Marina H de Jager, Wouter L J Hinrichs, Peter Olinga, Barbro N Melgert
Osteoprotegerin is an Early Marker of the Fibrotic Process and of Antifibrotic Treatment Responses in Ex Vivo Lung Fibrosis. Lung (2024)
Kurnia S S Putri, Adhyatmika Adhyatmika, Carian E Boorsma, Habibie Habibie, Mitchel J R Ruigrok, Peter Heukels, Hidde J Haisma, Marina H de Jager, Wouter L J Hinrichs, Peter Olinga, Barbro N Melgert
Osteoprotegerin is an Early Marker of the Fibrotic Process and of Antifibrotic Treatment Responses in Ex Vivo Lung Fibrosis. Lung 202 (3) (2024)
Kurnia S S Putri, Adhyatmika Adhyatmika, Carian E Boorsma, Habibie Habibie, Mitchel J R Ruigrok, Peter Heukels, Hidde J Haisma, Marina H de Jager, Wouter L J Hinrichs, Peter Olinga, Barbro N Melgert
Osteoprotegerin is an Early Marker of the Fibrotic Process and of Antifibrotic Treatment Responses in Ex Vivo Lung Fibrosis. Lung 202 (3) (2024)
Kurnia S S Putri, Adhyatmika Adhyatmika, Carian E Boorsma, Habibie Habibie, Mitchel J R Ruigrok, Peter Heukels, Hidde J Haisma, Marina H de Jager, Wouter L J Hinrichs, Peter Olinga, Barbro N Melgert
Osteoprotegerin is an Early Marker of the Fibrotic Process and of Antifibrotic Treatment Responses in Ex Vivo Lung Fibrosis. Lung 202 (3) (2024)
Primawan Putra Nugrahadi, Wouter L J Hinrichs, Henderik W Frijlink, Christian Schöneich, Christina Avanti
Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review. Pharmaceutics 15 (3) (2023)
Renée S van der Kooij, Martin Beukema, Anke L W Huckriede, Johan Zuidema, Rob Steendam, Henderik W Frijlink, Wouter L J Hinrichs
A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice. Pharmaceutics 15 (2) (2023)
Renée S van der Kooij, Martin Beukema, Anke L W Huckriede, Johan Zuidema, Rob Steendam, Henderik W Frijlink, Wouter L J Hinrichs
A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice. Pharmaceutics 15 (2) (2023)
Primawan Putra Nugrahadi, Wouter L J Hinrichs, Henderik W Frijlink, Christian Schöneich, Christina Avanti
Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review. Pharmaceutics 15 (3) (2023)
Primawan Putra Nugrahadi, Wouter L J Hinrichs, Henderik W Frijlink, Christian Schöneich, Christina Avanti
Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review. Pharmaceutics 15 (3) (2023)
Renée S van der Kooij, Martin Beukema, Anke L W Huckriede, Johan Zuidema, Rob Steendam, Henderik W Frijlink, Wouter L J Hinrichs
A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice. Pharmaceutics 15 (2) (2023)
Rick Heida, Paul Hagedoorn, Melle C van Meel, Jurrie E R Prins, Frederike S Simonis, Renate Akkerman, Anke L W Huckriede, Henderik W Frijlink, Anne H de Boer, Wouter L J Hinrichs
Performance Testing of a Homemade Aerosol Generator for Pulmonary Administration of Dry Powder Formulations to Mice. Pharmaceutics 15 (7) (2023)
Khanh T T Nguyen, Daan Zillen, Franca F M Heijningen, Kjeld J C van Bommel, Renz J van Ee, Henderik W Frijlink, Wouter L J Hinrichs
Surface Engineering Methods for Powder Bed Printed Tablets to Optimize External Smoothness and Facilitate the Application of Different Coatings. Pharmaceutics 15 (9) (2023)
Rick Heida, Philip A Born, Gabriela Tapia-Calle, Henderik W Frijlink, Anna Salvati, Anke L W Huckriede, Wouter L J Hinrichs
Assessing the Immunomodulatory Effect of Size on the Uptake and Immunogenicity of Influenza- and Hepatitis B Subunit Vaccines In Vitro. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)
Evalyne M Jansen, Henderik W Frijlink, Wouter L J Hinrichs, Mitchel J R Ruigrok
Are inhaled mRNA vaccines safe and effective? A review of preclinical studies. Expert opinion on drug delivery 19 (11) (2022)
Khanh T T Nguyen, Franca F M Heijningen, Daan Zillen, Kjeld J C van Bommel, Renz J van Ee, Henderik W Frijlink, Wouter L J Hinrichs
Formulation of a 3D Printed Biopharmaceutical: The Development of an Alkaline Phosphatase Containing Tablet with Ileo-Colonic Release Profile to Treat Ulcerative Colitis. Pharmaceutics 14 (10) (2022)
Rick Heida, Wouter L J Hinrichs, Henderik W Frijlink
Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19. Expert review of vaccines (2021)
Renée S van der Kooij, Rob Steendam, Johan Zuidema, Henderik W Frijlink, Wouter L J Hinrichs
Microfluidic Production of Polymeric Core-Shell Microspheres for the Delayed Pulsatile Release of Bovine Serum Albumin as a Model Antigen. Pharmaceutics 13 (11) (2021)
Annemarie Broesder, Julia M E Berends, Sophie M Scheepers, Duong N Nguyen, Henderik W Frijlink, Wouter L J Hinrichs
Ileo-Colon Targeting of the Poorly Water-Soluble Drug Celecoxib Using a pH-Dependent Coating in Combination with Self-Emulsifying Drug Delivery or Solid Dispersion Systems. Pharmaceutics 13 (5) (2021)
Annemarie Broesder, Said Y Bircan, Anneko B de Waard, Anko C Eissens, Henderik W Frijlink, Wouter L J Hinrichs
Formulation and In Vitro Evaluation of Pellets Containing Sulfasalazine and Caffeine to Verify Ileo-Colonic Drug Delivery. Pharmaceutics 13 (12) (2021)
Yu Tian, Yoshita C Bhide, Herman J Woerdenbag, Anke L W Huckriede, Henderik W Frijlink, Wouter L J Hinrichs, J Carolina Visser
Development of an Orodispersible Film Containing Stabilized Influenza Vaccine. Pharmaceutics 12 (3) (2020)
Katie Amssoms, Philip A Born, Max Beugeling, Ben De Clerck, Ellen Van Gulck, Wouter L J Hinrichs, Henderik W Frijlink, Niels Grasmeijer, Guenter Kraus, Roger Sutmuller, Kenny Simmen, Lieven Baert
Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice. PloS one 13 (8) (2018)